{"gene":"MAFA","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2002,"finding":"MAFA (RIPE3b1) was identified as the mammalian homologue of avian MafA/L-Maf by biochemical purification and shown to specifically bind the insulin enhancer element RIPE3b and activate insulin gene expression; it is selectively expressed in pancreatic beta cells but not alpha cells.","method":"Biochemical purification, DNA binding assay (EMSA), reporter gene assay, RT-PCR","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct biochemical purification plus functional reporter assay, replicated by independent lab same year (PMID:12368292)","pmids":["12011435","12368292"],"is_preprint":false},{"year":2002,"finding":"MafA protein and mRNA are up-regulated by glucose in pancreatic beta cells, and MafA binds the RIPE3b element in a glucose-dependent manner; dominant-negative MafA inhibits insulin promoter activity in beta cell lines.","method":"RT-PCR, EMSA, transient transfection reporter assay, dominant-negative construct","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (binding assay, reporter assay, dominant-negative), replicated across labs","pmids":["12368292"],"is_preprint":false},{"year":2004,"finding":"MafA selectively induces endogenous insulin transcription in non-beta cells, making it the only beta cell-specific activator of the insulin gene; MafA expression is first detected during the second principal phase of beta cell differentiation and is absent in Nkx6.1-null pancreata.","method":"Ectopic expression in non-beta cell lines, in vivo mouse genetic model (Nkx6.1-/-), immunostaining","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function genetic model combined with ectopic expression assay, two orthogonal approaches","pmids":["14973194"],"is_preprint":false},{"year":2005,"finding":"MafA physically interacts with endogenous PDX-1 and BETA2 (NeuroD) in beta cells, and together these three factors synergistically activate insulin promoter activity; synergy requires MafA transactivation and DNA-binding activity.","method":"Co-immunoprecipitation, GST pull-down, transfection reporter assay, dominant-negative and siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reciprocal Co-IP plus GST pull-down plus functional reporter assays with mutagenesis","pmids":["15665000"],"is_preprint":false},{"year":2005,"finding":"MafA-deficient mice display glucose intolerance and develop diabetes mellitus with severely impaired glucose-, arginine-, and KCl-stimulated insulin secretion, reduced Pdx1, Beta2, Glut-2, and insulin transcripts, demonstrating MafA is a key in vivo regulator of glucose-stimulated insulin secretion.","method":"Knockout mouse model, glucose tolerance test, insulin secretion assay, RT-PCR","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout mouse with multiple defined phenotypic readouts","pmids":["15923615"],"is_preprint":false},{"year":2005,"finding":"FoxO1 protects beta cells against oxidative stress by forming a complex with PML and SIRT1 to activate MafA (and NeuroD) expression; hyperglycemia suppresses MafA expression in vivo and this can be prevented by constitutively nuclear FoxO1.","method":"Coimmunoprecipitation (FoxO1-Pml-Sirt1 complex), acetylation-defective/mimicking mutants, transgenic mouse model, in vivo glucose manipulation","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — complex identification by Co-IP plus transgenic mouse rescue experiment","pmids":["16154098"],"is_preprint":false},{"year":2001,"finding":"Phosphorylation of MafA at serines 14 and 65 (located in the transcriptional activating domain) is essential for its transcriptional activity and biological functions including induction of differentiation programs; these residues are phosphorylated by ERK2 in vitro.","method":"In vitro kinase assay (ERK2), site-directed mutagenesis (S14A, S65A), reporter gene assay, in ovo electroporation differentiation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and functional validation, single lab","pmids":["11416124"],"is_preprint":false},{"year":2006,"finding":"FoxA2, Nkx2.2, and PDX-1 bind in vivo to conserved region 3 (bp -8118 to -7750) of the mafA promoter to drive beta cell-specific mafA transcription; Nkx2.2-null animals lack MafA expression in the pancreatic epithelium, and PDX-1 knockdown decreases mafA mRNA.","method":"Chromatin immunoprecipitation (ChIP), EMSA, site-directed mutagenesis, reporter assay, siRNA knockdown, Nkx2.2 knockout mouse","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP plus mutagenesis plus genetic loss-of-function model","pmids":["16847327"],"is_preprint":false},{"year":2006,"finding":"MAFA overproduction enhances and dominant-negative MAFA diminishes binding to the insulin promoter, correlating with insulin mRNA and protein levels; MAFA also positively regulates glucokinase, Glut2, PDX1, NKX6-1, GLP1R, PCSK1, and pyruvate carboxylase expression in beta cell lines.","method":"Inducible stable cell lines (overexpression and dominant-negative), EMSA, RT-PCR, Western blot, insulin secretion assay","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain- and loss-of-function in isogenic cell lines with multiple target gene readouts","pmids":["17149590"],"is_preprint":false},{"year":2007,"finding":"MafA protein stability is regulated by glycogen synthase kinase 3 (GSK3): GSK3 constitutively phosphorylates the MafA N-terminal region at multiple sites, and this phosphorylation is a prerequisite for rapid MafA protein degradation under low-glucose conditions.","method":"Mutational analysis of MafA phosphorylation sites, pharmacological GSK3 inhibition in MIN6 beta cells, pulse-chase/degradation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — site-directed mutagenesis combined with pharmacological inhibition and protein stability assay","pmids":["17682063"],"is_preprint":false},{"year":2008,"finding":"Phosphorylation at Ser65 of MafA controls both protein stability and transactivation potential; phosphorylation at Ser65 is the initial degradation signal, with ubiquitination occurring in the C-terminus; phosphorylation at Ser65 acts as primer for subsequent GSK3-mediated phosphorylation at neighboring N-terminal residues; Ser65 phosphorylation is required for polyubiquitination.","method":"Site-directed mutagenesis (S65E, S65D, S65A), ubiquitination assay, proteasome degradation assay, reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution-level mutagenesis with mechanistic dissection of phosphorylation-ubiquitination cascade","pmids":["19004825"],"is_preprint":false},{"year":2008,"finding":"Sumoylation of MafA at Lys32 reduces its transcriptional activity toward the insulin gene promoter and increases repression of the CHOP-10 promoter; low glucose and hydrogen peroxide increase endogenous MafA sumoylation; sumoylation does not affect nuclear localization or ubiquitin-dependent degradation.","method":"SUMO modification assay, site-directed mutagenesis (K32R), reporter gene assay, beta cell treatment with glucose/H2O2","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct biochemical modification assay with mutagenesis and functional reporter readout","pmids":["19029092"],"is_preprint":false},{"year":2009,"finding":"p38 MAPK directly binds to MafA and regulates MafA protein stability under both basal and oxidative stress conditions; under oxidative stress p38 MAPK-mediated phosphorylation at threonine 57 and threonine 134 drives MafA degradation via the ubiquitin-proteasomal pathway; inhibiting p38 MAPK (but not GSK3) prevents oxidative stress-dependent MafA degradation.","method":"p38 MAPK inhibitor treatment, site-directed mutagenesis (T57A, T134A), Co-IP (p38-MafA binding), protein stability assay, isolated mouse islets","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct binding shown by Co-IP, mutagenesis identifies specific phosphorylation sites, functional degradation assay","pmids":["19407223"],"is_preprint":false},{"year":2010,"finding":"Phosphorylation within the MafA N-terminal transactivation domain (aa 1-72) is required for C-terminal dimerization and DNA binding; dephosphorylation precludes detection of MafA dimers and dramatically reduces DNA binding; this phosphorylation dependency is unique to MafA and not shared by MafB.","method":"Mass spectrometry (phosphorylation site mapping), MafA/MafB chimeric proteins, dephosphorylation assay, EMSA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mass spectrometry plus chimeric protein analysis plus EMSA, identifying a novel structural mechanism","pmids":["20208071"],"is_preprint":false},{"year":2003,"finding":"The islet beta cell-enriched RIPE3b1/MafA transcription factor binds to sequence blocks 4 and 5 (B4/5) within the pdx-1 gene Area II control region and activates pdx-1 transcription; ChIP confirmed MafA occupancy at the endogenous pdx-1 Area II region.","method":"EMSA, reporter assay with mutagenesis, chromatin immunoprecipitation (ChIP)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct DNA binding (EMSA), promoter mutagenesis, and in vivo ChIP confirming endogenous occupancy","pmids":["12551916"],"is_preprint":false},{"year":2005,"finding":"MafA, PDX-1, and BETA2 synergistically activate the insulin promoter; mutagenesis shows at least GG2, C1, and E1 elements (within -150 to -100 bp) are necessary for synergy; neither MafB nor c-Maf shows the same synergistic activation with PDX-1 and BETA2.","method":"Transient transfection reporter assay, promoter deletion and mutagenesis","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic promoter mutagenesis in beta cell lines, single lab","pmids":["15993959"],"is_preprint":false},{"year":2005,"finding":"MafA phosphorylation by p38 MAP kinase occurs at threonine 113, threonine 57, and serine 272; mutation of these residues severely impairs MafA biological activity; p38 also phosphorylates MafB and c-Maf.","method":"Western blot, mass spectrometry, in vitro kinase assay, site-directed mutagenesis, reporter/biological activity assay","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus mass spectrometry identification of sites plus mutagenesis functional validation","pmids":["15963504"],"is_preprint":false},{"year":2006,"finding":"Glucose-induced MafA expression in beta cells requires flux through the hexosamine biosynthetic pathway and O-linked glycosylation by UDP-N-acetylglucosaminyl transferase; glucosamine stimulates MafA expression in the absence of high glucose, and inhibition of the hexosamine pathway abolishes glucose-induced MafA induction.","method":"Pharmacological inhibition (glucosamine supplementation, hexosamine pathway inhibitors, OGT inhibitor/activator), RT-PCR, Western blot in beta cell lines","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection with multiple compounds, single lab, indirect evidence for O-GlcNAc-mediated regulation","pmids":["17142462"],"is_preprint":false},{"year":2008,"finding":"MafA and MafB regulate Pdx1 transcription exclusively through the Area II control region; in adult islets only MafA is bound to Area II by quantitative ChIP; both MafA and MafB are bound to Area II at E18.5 during development; MafB-/- mice show severely compromised Pdx1 Area I/II transgene expression.","method":"Transfection reporter assay, quantitative ChIP, MafB knockout mouse model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — quantitative ChIP plus loss-of-function mouse model","pmids":["18522939"],"is_preprint":false},{"year":2010,"finding":"Region 3 (bp -8118 to -7750) of the mafA promoter is necessary but not sufficient for beta cell-specific in vivo expression; full promoter (R1-6) is required including region 3; Nkx6.1 and Pax6 (but not NeuroD1) bind to and activate MafA through region 3 in ChIP and transfection assays and in vivo knockout models.","method":"Transgenic reporter mice (R3, R1-6, R1-6ΔR3), ChIP, EMSA, transfection assay, mouse knockout models","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple transgenic reporter lines, ChIP, and genetic knockout models","pmids":["20584984"],"is_preprint":false},{"year":2011,"finding":"ATF2 forms a complex with MafA and acquires the capacity to bind the C1/RIPE3b element; co-expression of ATF2, MafA, PDX-1, and BETA2 produces synergistic activation of the insulin promoter; RNAi knockdown of ATF2 or MafA decreases endogenous insulin mRNA in MIN6 cells.","method":"Co-immunoprecipitation, EMSA, reporter assay, RNAi knockdown, immunohistochemistry","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus EMSA plus functional knockdown, single lab","pmids":["21278380"],"is_preprint":false},{"year":2011,"finding":"Proteasome activator PA28γ binds to GSK3-phosphorylated MAFA, stimulates its proteasomal degradation, and attenuates MAFA-driven insulin promoter activity; MAFA phosphorylation-site mutants (alanine substitutions at Ser49, Thr53, Thr57, Ser61, Ser65) do not bind PA28γ and are resistant to degradation; PA28γ degrades MAFA through a mechanism distinct from p21 degradation.","method":"Co-immunoprecipitation (PA28γ-MAFA), proteasome degradation assay, site-directed mutagenesis, reporter assay, PA28γ mutant analysis","journal":"Journal of molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct binding by Co-IP, mutagenesis of phosphorylation sites, functional reporter assay","pmids":["21646385"],"is_preprint":false},{"year":2010,"finding":"SUMOylation at a conserved lysine residue in the MafA N-terminal transactivator domain negatively regulates its transcriptional and oncogenic activities; a SUMOylation-deficient mutant (K32R) shows enhanced transactivation of crystallin and insulin promoters and enhanced colony formation.","method":"SUMO modification assay, site-directed mutagenesis (K32R), reporter gene assay, in ovo electroporation, colony formation assay","journal":"Genes to cells","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct SUMO modification assay with mutagenesis and multiple functional readouts","pmids":["20718938"],"is_preprint":false},{"year":2015,"finding":"MafA associates with the MLL3 and MLL4 histone H3K4 methyltransferase complexes (~1.5 MDa) in beta cell extracts; all subunits of MLL3/4 complexes were identified by unbiased mass spectrometry; NCOA6 knockdown (a core MLL3/4 subunit) reduces expression of a subset of MafA target genes in mouse and human beta cell lines.","method":"In-cell biochemistry/mass spectrometry (unbiased pulldown), size-fractionation Co-IP, siRNA knockdown, islet-specific NCoA6 knockout mouse","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — unbiased mass spectrometry identification plus size-fractionation Co-IP plus genetic knockout validation","pmids":["26180087"],"is_preprint":false},{"year":2013,"finding":"Thyroid hormone (T3) has a direct receptor-ligand interaction with the Mafa promoter (shown by ChIP and EMSA) and this interaction is functional in a luciferase reporter assay; dominant-negative Mafa abolishes T3-enhanced glucose-responsive insulin secretion, placing Mafa downstream of thyroid hormone signaling for beta cell functional maturation.","method":"Chromatin immunoprecipitation, EMSA, luciferase reporter assay, dominant-negative Mafa, in vivo T3 supplementation/inhibition in neonatal rats","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct promoter binding (ChIP + EMSA), functional reporter, and dominant-negative epistasis in vivo","pmids":["23305647"],"is_preprint":false},{"year":2018,"finding":"A missense MAFA mutation (p.Ser64Phe) impairs phosphorylation within the transactivation domain, profoundly increases MAFA protein stability under both high and low glucose, and enhances transactivation potential in beta cell lines, causing familial insulinomatosis or diabetes.","method":"Exome sequencing (disease mutation identification), phosphorylation assay, protein stability assay in beta cell lines, reporter assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — biochemical demonstration of impaired phosphorylation and increased stability with multiple assays in two families","pmids":["29339498"],"is_preprint":false},{"year":2021,"finding":"The MAFA S64F mutation causes accelerated cellular senescence and increased senescence-associated secretory proteins in male human beta cells; male MafAS64F/+ mice show transiently higher MafA protein levels, sex-dependent changes in Ca2+ signaling, DNA damage, and aging genes preceding glucose intolerance.","method":"S64F MafA knock-in mouse model, human beta cell expression system, senescence assays, gene expression profiling","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — knock-in mouse model plus human beta cell experiments with functional senescence readouts","pmids":["34644565"],"is_preprint":false},{"year":2013,"finding":"p38 MAPK directly binds to MafA and promotes its degradation through the ubiquitin proteasomal pathway under oxidative stress; degradation under oxidative stress depends specifically on p38 MAPK-mediated phosphorylation at T134 (not T57); expression of T134A-MafA but not T57A-MafA reduces oxidative stress-mediated loss of glucose-stimulated insulin secretion; PA28γ expression is reduced under oxidative stress, explaining the dominance of p38 MAPK over GSK3 in this context.","method":"Site-directed mutagenesis (T134A, T57A), Co-IP (p38-MafA), ubiquitin assay, insulin secretion assay, Western blot","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct binding Co-IP plus mutagenesis distinguishing two phosphorylation sites, functional secretion assay","pmids":["23660596"],"is_preprint":false},{"year":2016,"finding":"MAFA controls ANS-mediated insulin secretion by activating transcription of nicotinic receptor genes (ChrnB2, ChrnB4) and adrenergic receptor gene (Adra2A) in beta cells; acetylcholine-mediated insulin secretion requires nicotinic signaling; shown in MafA-deficient mouse model and human islet correlation studies.","method":"MafA-deficient mouse model, ChIP, reporter assay, insulin secretion assay with nicotinic/adrenergic agonists, human islet gene expression analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function mouse model plus ChIP plus functional insulin secretion assay","pmids":["26904947"],"is_preprint":false},{"year":2019,"finding":"MafA directly binds to transcriptional control sequences of MaoA and MaoB genes (monoamine oxidases) in beta cells, activating their expression; MaoB expression is reduced in MafA-deficient mouse islets; inhibition of Mao activity reduces insulin secretion.","method":"ChIP (MafA binding to MaoA/MaoB promoters), MafA knockout mouse, pharmacological Mao inhibition, insulin secretion assay","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct ChIP plus loss-of-function mouse model plus functional secretion assay","pmids":["26546820"],"is_preprint":false},{"year":2019,"finding":"MafA controls expression of the calcium channel subunit CaVγ4, as verified by ChIP and experiments in beta cell-specific MafA knockout mice; reduced CaVγ4 leads to decreased CaV1.2 and CaV1.3 expression and suppresses voltage-gated Ca2+ entry and glucose-stimulated insulin exocytosis.","method":"ChIP (MafA at CaVγ4 locus), beta cell-specific MafA knockout mouse, patch-clamp/Ca2+ imaging, insulin exocytosis assay","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct ChIP plus conditional knockout mouse with functional calcium and secretion readouts","pmids":["30911681"],"is_preprint":false},{"year":2021,"finding":"MafA regulates expression of the PPP1R1A (protein phosphatase 1 inhibitor protein 1A) gene in beta cells; PPP1R1A silencing impairs GLP1-mediated glucose-stimulated insulin secretion amplification, PKA-target protein phosphorylation, and mitochondrial coupling efficiency, and causes beta cell dedifferentiation.","method":"MafA knockout mouse (gene expression profiling), siRNA knockdown of PPP1R1A, insulin secretion assay, PKA phosphorylation assay, mitochondrial coupling assay","journal":"Metabolism: clinical and experimental","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in mouse model plus functional beta cell assays, single lab","pmids":["33631146"],"is_preprint":false},{"year":2022,"finding":"MAFA and MAFB regulate exocytosis-related genes in human beta cells including STX1A, SYT7, and STXBP1; MAFA/MAFB silencing impairs insulin secretion and reduces STX1A, SYT7, and STXBP1 mRNA; STX1A and STXBP1 protein expression is impaired in islets from T2D donors lacking MAFA.","method":"RNAseq (MafA-/- mouse islets), MAFA/MAFB siRNA knockdown in human islets and EndoC-βH1 cells, insulin secretion assay, Western blot","journal":"Acta physiologica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in mouse and human beta cell models, functional secretion assay, single lab","pmids":["34978761"],"is_preprint":false},{"year":2020,"finding":"Kindlin-2 binds to MafA through its C-terminal region, stabilizes MafA protein, and thereby activates insulin expression; Kindlin-2 loss decreases MafA levels and impairs insulin secretion; Kindlin-2 loss also activates GSK-3β and downregulates β-catenin, reducing beta cell proliferation.","method":"Conditional beta cell-specific Kindlin-2 knockout mouse, Co-IP (Kindlin-2-MafA), domain mapping, protein stability assay, Ca2+ imaging, insulin secretion assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct Co-IP with domain mapping plus conditional knockout mouse with multiple mechanistic readouts","pmids":["31980627"],"is_preprint":false},{"year":2022,"finding":"METTL3-mediated m6A methylation regulates MafA mRNA stability and expression; METTL3 silencing reduces m6A levels, MafA mRNA stability, and MafA protein; MafA overexpression rescues the impaired glucose-stimulated insulin secretion caused by METTL3 silencing.","method":"METTL3 siRNA knockdown, m6A measurement, mRNA stability assay, MafA overexpression rescue, insulin secretion assay in NIT-1 and β-TC-6 cells","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct mRNA stability assay plus epistasis rescue experiment, single lab","pmids":["35872977"],"is_preprint":false},{"year":2014,"finding":"Loss of MafA in knockout mice reduces the beta-to-alpha cell ratio and leads to beta cell dedifferentiation, including reduced/lost insulin expression and conversion of a minority of beta cells to glucagon-expressing cells; re-expression of Mafb (an immature beta cell marker) is observed in dedifferentiated beta cells in MafA KO and diabetic mouse models.","method":"MafA knockout mouse, lineage tracing, transcriptome analysis, immunostaining","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 2 / Strong — lineage tracing plus transcriptome analysis in knockout model defines cell fate mechanism","pmids":["25500951"],"is_preprint":false},{"year":2014,"finding":"MafA regulates postnatal beta cell replication through the prolactin receptor (Prlr) and cyclin D2 (Ccnd2); MafA directly transactivates the Prlr promoter; loss of MafA reduces Prlr and Ccnd2 expression and impairs beta cell proliferation at 4 weeks of age.","method":"MafA knockout mouse, transcriptome analysis, reporter assay (Prlr promoter), siRNA knockdown, BrdU proliferation assay, Western blot","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct promoter activation assay plus knockout mouse with proliferation phenotype","pmids":["25126749"],"is_preprint":false},{"year":2009,"finding":"Expression of MafA in Pdx1+ pancreatic progenitors reduces pancreatic mass and proliferation of progenitors, at least partially through induction of cyclin kinase inhibitors p27 and p57, and disproportionately inhibits formation of endocrine cells.","method":"Conditional MafA transgene expression in Pdx1+ progenitors (in vivo mouse), cell cycle analysis, immunostaining for p27/p57","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional transgenic mouse with mechanistic marker analysis, single lab","pmids":["19576197"],"is_preprint":false},{"year":2003,"finding":"MafA is able to bind MARE sequences and heterodimerize with v-Maf, MafB, Jun, and Fos, but not with small Maf proteins (MafF, MafK); increased expression of mafA in neuroretina induces sustained proliferation of postmitotic cells.","method":"EMSA, co-immunoprecipitation (heterodimerization), overexpression in QNR cells (proliferation assay)","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — EMSA and Co-IP dimerization assays plus functional proliferation assay, avian ortholog data","pmids":["9674710"],"is_preprint":false},{"year":2003,"finding":"MafA cell-transforming ability is correlated with its DNA-binding domain (from chimeric MafA/MafB analysis); transactivation and transformation by MafA are controlled by phosphorylation of two conserved serine residues in the transactivation domain; MafA is a weaker transactivator than MafB or c-Maf but the strongest inducer of cellular transformation.","method":"Reporter assay, chicken embryo fibroblast transformation assay, MafA/MafB chimeric proteins, site-directed mutagenesis, MafA-estrogen receptor fusion","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — chimeric protein and mutagenesis analysis with functional transformation assay, single lab","pmids":["12970735"],"is_preprint":false},{"year":2010,"finding":"c-Jun expression is increased in diabetic db/db islets and directly suppresses MafA expression; adenoviral overexpression of c-Jun in MIN6 cells and isolated islets significantly decreases MafA expression and insulin expression; MafA overexpression restores insulin promoter activity suppressed by c-Jun.","method":"db/db mouse model (immunohistochemistry, Western blot), adenoviral overexpression of c-Jun, reporter assay, MafA rescue experiment","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function in primary islets plus in vivo pathological correlation and rescue experiment","pmids":["20424231"],"is_preprint":false},{"year":2015,"finding":"HMGA1 physically interacts with PDX-1 and MafA both in vitro and in vivo; HMGA1 overexpression enhances the transactivating activity of PDX-1 and MafA on insulin promoters; HMGA1 knockdown decreases this activity; glucose increases HMGA1 binding to the insulin gene promoter.","method":"Co-immunoprecipitation, GST pull-down, reporter assay (overexpression and knockdown), ChIP","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus GST pull-down plus reporter assay, single lab","pmids":["25628604"],"is_preprint":false},{"year":2010,"finding":"MafA regulates intrathymic insulin (Ins2) expression; MafA knockout mice show reduced thymic Ins2 expression and develop autoantibodies against pancreatic islets; MafA expression in thymus correlates with Ins2 expression in NOD mice.","method":"MafA knockout mouse, RT-PCR (thymic Ins2), autoantibody measurement, reporter assay for MafA polymorphisms","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout mouse with defined thymic gene expression and autoimmunity phenotype, single lab","pmids":["20682694"],"is_preprint":false}],"current_model":"MAFA is a beta cell-enriched basic leucine zipper transcription factor that binds the RIPE3b/C1 element of the insulin gene promoter and synergistically activates insulin transcription together with PDX-1 and BETA2/NeuroD; its activity and stability are tightly controlled by multi-site phosphorylation (by GSK3, p38 MAPK, and ERK2), SUMOylation at Lys32, and ubiquitin-proteasomal degradation (facilitated by PA28γ), with Ser65 phosphorylation serving as the priming signal for proteolysis; MAFA also directly regulates transcription of Pdx1, genes for glucose sensing, ion channels (CaVγ4), neurotransmitter receptors, and exocytosis machinery, and associates with MLL3/4 histone methyltransferase complexes to broadly activate beta cell gene programs, collectively making MAFA an essential master regulator of adult beta cell identity, glucose-stimulated insulin secretion, and postnatal beta cell proliferation."},"narrative":{"mechanistic_narrative":"MAFA is a beta cell-enriched basic leucine zipper transcription factor that serves as a master regulator of adult beta cell identity and glucose-stimulated insulin secretion [PMID:12011435, PMID:12368292, PMID:15923615]. Originally purified as the RIPE3b1 activity that binds the RIPE3b/C1 enhancer element of the insulin gene, it is the only known beta cell-specific factor capable of inducing endogenous insulin transcription in non-beta cells [PMID:12011435, PMID:12368292, PMID:14973194], and it activates insulin transcription synergistically with PDX-1 and BETA2/NeuroD through physical complex formation on the proximal promoter [PMID:15665000, PMID:15993959]. MAFA functions at the apex of a beta cell transcriptional network: it directly drives Pdx1 transcription through the Area II control region [PMID:12551916, PMID:18522939] while itself being a target of upstream regulators including FoxA2, Nkx2.2, PDX-1, Nkx6.1, and Pax6 that confer beta cell-specific expression [PMID:16847327, PMID:20584984]. Beyond insulin, MAFA directly transactivates a broad beta cell functional program — glucose-sensing and metabolic genes [PMID:17149590], the voltage-gated calcium channel subunit CaVbeta4 governing Ca2+ entry and exocytosis [PMID:30911681], autonomic neurotransmitter receptors (nicotinic ChrnB2/B4 and adrenergic Adra2A) [PMID:26904947], monoamine oxidases MaoA/MaoB [PMID:26546820], and exocytosis machinery [PMID:34978761], and associates with the ~1.5 MDa MLL3/MLL4 H3K4 methyltransferase complexes to activate these target programs at the chromatin level [PMID:26180087]. MAFA activity and abundance are governed by an intricate post-translational network: multi-site N-terminal phosphorylation by ERK2, p38 MAPK, and GSK3 is required for dimerization, DNA binding, and transactivation, with Ser65 phosphorylation priming polyubiquitination and proteasomal degradation, the latter facilitated by the proteasome activator PA28gamma [PMID:11416124, PMID:19004825, PMID:20208071, PMID:21646385]; p38 MAPK-mediated phosphorylation at Thr134 selectively drives MAFA degradation under oxidative stress [PMID:19407223, PMID:23660596], while SUMOylation at Lys32 dampens its transactivation [PMID:19029092, PMID:20718938]. MAFA is required for postnatal beta cell proliferation through the prolactin receptor and cyclin D2 [PMID:25126749] and for maintaining differentiated beta cell identity, since its loss causes beta cell dedifferentiation and conversion toward glucagon/MafB-expressing states [PMID:25500951]. A heterozygous MAFA p.Ser64Phe missense mutation that impairs transactivation-domain phosphorylation and stabilizes the protein causes familial insulinomatosis or diabetes [PMID:29339498].","teleology":[{"year":2001,"claim":"Before MAFA's beta cell role was known, its avian ortholog established that transactivation-domain phosphorylation is a prerequisite for Maf transcriptional and differentiation activity, defining the regulatory principle that would later govern MAFA function.","evidence":"In vitro ERK2 kinase assay with S14A/S65A mutagenesis and in ovo electroporation differentiation assay","pmids":["11416124"],"confidence":"High","gaps":["Did not address mammalian beta cell context","Kinases acting in vivo not identified"]},{"year":2002,"claim":"Identifying the long-sought RIPE3b1 insulin enhancer activity as the mammalian MAFA established it as a beta cell-selective insulin transcription factor and the molecular basis of glucose-responsive insulin gene control.","evidence":"Biochemical purification, EMSA, reporter assay, RT-PCR, plus glucose-dependent binding and dominant-negative inhibition in beta cell lines","pmids":["12011435","12368292"],"confidence":"High","gaps":["In vivo requirement not yet demonstrated","Mechanism of glucose responsiveness unresolved"]},{"year":2004,"claim":"Demonstrating that MAFA alone induces endogenous insulin in non-beta cells and is absent in Nkx6.1-null pancreata positioned it as a uniquely sufficient, developmentally regulated beta cell determinant.","evidence":"Ectopic expression in non-beta lines and Nkx6.1-/- mouse with immunostaining","pmids":["14973194"],"confidence":"High","gaps":["Direct vs indirect downstream of Nkx6.1 not separated at this stage"]},{"year":2005,"claim":"Establishing physical and functional synergy of MAFA with PDX-1 and BETA2, and the in vivo diabetic phenotype of MafA-deficient mice, defined MAFA as a non-redundant node coordinating the insulin transcription complex and glucose-stimulated secretion.","evidence":"Co-IP/GST pull-down with reporter mutagenesis, plus knockout mouse with glucose tolerance and insulin secretion assays","pmids":["15665000","15923615","15993959"],"confidence":"High","gaps":["Stoichiometry and architecture of the trimeric complex unresolved","Distinction between secretory and transcriptional contributions to phenotype incomplete"]},{"year":2006,"claim":"Mapping the beta cell-specific MafA promoter to a FoxA2/Nkx2.2/PDX-1-bound conserved region placed MAFA within a transcriptional hierarchy and connected its glucose induction to the hexosamine/O-GlcNAc pathway.","evidence":"ChIP, EMSA, reporter mutagenesis, Nkx2.2 knockout, and pharmacological hexosamine pathway dissection","pmids":["16847327","17142462","17149590"],"confidence":"High","gaps":["Direct O-GlcNAc modification of MAFA itself not established","Promoter-level regulators incompletely enumerated"]},{"year":2008,"claim":"Resolving the Ser65-primed phosphorylation/ubiquitination cascade and Lys32 SUMOylation revealed how kinase signaling and SUMO converge to tune MAFA stability and transcriptional output as a glucose- and stress-responsive rheostat.","evidence":"Site-directed mutagenesis (S65 variants, K32R), ubiquitination/degradation assays, reporter assays, and GSK3 pharmacology","pmids":["19004825","19029092","17682063"],"confidence":"High","gaps":["E3 ligase mediating C-terminal ubiquitination not identified","SUMO ligase/protease not defined"]},{"year":2010,"claim":"Demonstrating that N-terminal phosphorylation is required for C-terminal dimerization and DNA binding uncovered a MAFA-unique structural mechanism coupling signaling to DNA occupancy.","evidence":"Mass spectrometry site mapping, MafA/MafB chimeras, dephosphorylation assay, EMSA","pmids":["20208071","20718938","20584984"],"confidence":"High","gaps":["Structural basis of phosphorylation-dependent dimerization not solved","Which physiological kinase sets the DNA-binding-competent state in beta cells unclear"]},{"year":2011,"claim":"Identifying PA28gamma as the activator coupling GSK3-phosphorylated MAFA to proteasomal degradation, and ATF2 as a partner enhancing insulin promoter synergy, expanded both the destruction and the assembly arms of MAFA regulation.","evidence":"Co-IP, proteasome degradation assays, phosphosite mutagenesis (PA28gamma); Co-IP, EMSA, RNAi (ATF2)","pmids":["21646385","21278380"],"confidence":"High","gaps":["Whether PA28gamma acts ubiquitin-dependently or independently not fully resolved","ATF2 contribution in vivo untested"]},{"year":2013,"claim":"Defining thyroid hormone as a direct upstream input to the Mafa promoter and Thr134-specific p38 phosphorylation as the oxidative-stress degradation trigger linked MAFA to functional maturation signals and stress vulnerability.","evidence":"ChIP/EMSA/reporter with dominant-negative epistasis in neonatal rats; T134A/T57A mutagenesis with Co-IP and insulin secretion assays","pmids":["23305647","23660596"],"confidence":"High","gaps":["Crosstalk between maturation signals and stress-driven degradation not integrated","p38 upstream activators in beta cells not defined"]},{"year":2014,"claim":"Knockout studies established that MAFA is required to maintain differentiated beta cell identity and to drive postnatal beta cell replication, extending its role from gene activation to cell-fate stability and proliferation.","evidence":"MafA knockout mice with lineage tracing, transcriptome analysis; Prlr promoter reporter and BrdU proliferation assays","pmids":["25500951","25126749"],"confidence":"High","gaps":["Mechanism converting beta cells toward glucagon/MafB states incompletely defined","Direct vs indirect control of proliferation machinery partially resolved"]},{"year":2015,"claim":"Discovering MAFA association with MLL3/MLL4 H3K4 methyltransferase complexes and the HMGA1 coactivator provided the chromatin-level mechanism by which MAFA broadly activates beta cell gene programs.","evidence":"Unbiased mass spectrometry, size-fractionation Co-IP, NCOA6 knockdown/knockout; Co-IP, GST pull-down, ChIP for HMGA1","pmids":["26180087","25628604"],"confidence":"High","gaps":["Genome-wide MAFA-dependent H3K4 methylation landscape not mapped","Recruitment determinants of MLL3/4 by MAFA unknown"]},{"year":2018,"claim":"Identifying the MAFA p.Ser64Phe mutation that impairs phosphorylation and stabilizes the protein causally linked MAFA dysregulation to a human Mendelian disease spectrum of insulinomatosis and diabetes.","evidence":"Exome sequencing in two families, phosphorylation and protein stability assays, reporter assays in beta cell lines","pmids":["29339498"],"confidence":"High","gaps":["Why the same mutation causes opposite phenotypes (insulinomatosis vs diabetes) unresolved at this stage"]},{"year":2019,"claim":"Mapping direct MAFA targets to calcium-channel, monoamine oxidase, and autonomic neurotransmitter receptor genes mechanistically connected MAFA to the secretory coupling machinery beyond insulin gene transcription.","evidence":"ChIP and beta cell-specific MafA knockout mice with patch-clamp/Ca2+ imaging, Mao inhibition, and insulin secretion assays","pmids":["30911681","26546820","26904947"],"confidence":"High","gaps":["Relative contribution of each target to overall secretory defect not quantified","Direct ChIP for all targets not uniformly established"]},{"year":2022,"claim":"Demonstrating MAFA control of exocytosis genes and PPP1R1A, its stabilization by Kindlin-2, m6A-dependent MafA mRNA control by METTL3, and S64F-driven senescence built a layered picture of MAFA regulation spanning mRNA stability, protein stability, secretory effectors, and beta cell aging.","evidence":"siRNA in human/mouse islets and cell lines, RNAseq, Co-IP/domain mapping, m6A and mRNA stability assays, S64F knock-in mouse with senescence assays","pmids":["34978761","33631146","31980627","35872977","34644565"],"confidence":"Medium","gaps":["Several effector links rest on single-lab loss-of-function without orthogonal in vivo confirmation","Sex-dependence of S64F senescence mechanism not fully explained"]},{"year":null,"claim":"How the multiple converging post-translational inputs (ERK2, p38, GSK3, PA28gamma, SUMO, Kindlin-2) and upstream signals are integrated in vivo to set MAFA dosage during health, stress, and the divergent S64F disease outcomes remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated quantitative model of MAFA stability control","E3 ligase and SUMO enzymes for MAFA unidentified","Genome-wide direct target/chromatin map in primary human beta cells incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,3,8,14,28,30]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,13,14,38]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[11,0]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,3,8,14]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,35,36]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[25,26]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[23]}],"complexes":["MLL3/MLL4 H3K4 methyltransferase complex","MAFA-PDX-1-BETA2/NeuroD insulin promoter complex"],"partners":["PDX1","NEUROD1","ATF2","PA28GAMMA","HMGA1","FERMT2","MAPK14","NCOA6"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96E93","full_name":"Killer cell lectin-like receptor subfamily G member 1","aliases":["C-type lectin domain family 15 member A","ITIM-containing receptor MAFA-L","MAFA-like receptor","Mast cell function-associated antigen"],"length_aa":195,"mass_kda":21.8,"function":"Plays an inhibitory role on natural killer (NK) cells and T-cell functions upon binding to their non-MHC ligands. May mediate missing self recognition by binding to a highly conserved site on classical cadherins, enabling it to monitor expression of E-cadherin/CDH1, N-cadherin/CDH2 and R-cadherin/CDH4 on target cells","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q96E93/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAFA","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MAFA","total_profiled":1310},"omim":[{"mim_id":"610303","title":"MAF bZIP TRANSCRIPTION FACTOR A; MAFA","url":"https://www.omim.org/entry/610303"},{"mim_id":"608968","title":"MAF bZIP TRANSCRIPTION FACTOR B; MAFB","url":"https://www.omim.org/entry/608968"},{"mim_id":"607141","title":"GLIOMA PATHOGENESIS-RELATED PROTEIN 2; GLIPR2","url":"https://www.omim.org/entry/607141"},{"mim_id":"604882","title":"NEUROGENIN 3; NEUROG3","url":"https://www.omim.org/entry/604882"},{"mim_id":"604874","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY G, MEMBER 1; KLRG1","url":"https://www.omim.org/entry/604874"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"skeletal muscle","ntpm":21.9}],"url":"https://www.proteinatlas.org/search/MAFA"},"hgnc":{"alias_symbol":["RIPE3b1","hMafA"],"prev_symbol":[]},"alphafold":{"accession":"Q96E93","domains":[{"cath_id":"3.10.100.10","chopping":"83-187","consensus_level":"high","plddt":96.2488,"start":83,"end":187}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96E93","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96E93-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96E93-F1-predicted_aligned_error_v6.png","plddt_mean":81.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAFA","jax_strain_url":"https://www.jax.org/strain/search?query=MAFA"},"sequence":{"accession":"Q96E93","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96E93.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96E93/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96E93"}},"corpus_meta":[{"pmid":"16154098","id":"PMC_16154098","title":"FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction.","date":"2005","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16154098","citation_count":496,"is_preprint":false},{"pmid":"15923615","id":"PMC_15923615","title":"MafA is a key regulator of glucose-stimulated insulin secretion.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15923615","citation_count":399,"is_preprint":false},{"pmid":"12011435","id":"PMC_12011435","title":"Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12011435","citation_count":268,"is_preprint":false},{"pmid":"12368292","id":"PMC_12368292","title":"MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12368292","citation_count":252,"is_preprint":false},{"pmid":"16580660","id":"PMC_16580660","title":"A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16580660","citation_count":240,"is_preprint":false},{"pmid":"29096722","id":"PMC_29096722","title":"PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration.","date":"2017","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29096722","citation_count":233,"is_preprint":false},{"pmid":"14973194","id":"PMC_14973194","title":"The MafA transcription factor appears to be responsible for tissue-specific expression of insulin.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14973194","citation_count":225,"is_preprint":false},{"pmid":"20627934","id":"PMC_20627934","title":"MafA and MafB regulate genes critical to beta-cells in a unique temporal manner.","date":"2010","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/20627934","citation_count":198,"is_preprint":false},{"pmid":"21719305","id":"PMC_21719305","title":"MafA and MafB activity in pancreatic β cells.","date":"2011","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/21719305","citation_count":172,"is_preprint":false},{"pmid":"17149590","id":"PMC_17149590","title":"MAFA controls genes implicated in insulin biosynthesis and secretion.","date":"2006","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/17149590","citation_count":167,"is_preprint":false},{"pmid":"15665000","id":"PMC_15665000","title":"The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15665000","citation_count":155,"is_preprint":false},{"pmid":"19819955","id":"PMC_19819955","title":"beta-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice.","date":"2009","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19819955","citation_count":152,"is_preprint":false},{"pmid":"7491105","id":"PMC_7491105","title":"The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression.","date":"1995","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/7491105","citation_count":142,"is_preprint":false},{"pmid":"21190012","id":"PMC_21190012","title":"Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells.","date":"2010","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/21190012","citation_count":132,"is_preprint":false},{"pmid":"17938503","id":"PMC_17938503","title":"PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function.","date":"2007","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/17938503","citation_count":127,"is_preprint":false},{"pmid":"8613527","id":"PMC_8613527","title":"Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator.","date":"1996","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8613527","citation_count":127,"is_preprint":false},{"pmid":"23305647","id":"PMC_23305647","title":"Thyroid hormone promotes postnatal rat pancreatic β-cell development and glucose-responsive insulin secretion through MAFA.","date":"2013","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/23305647","citation_count":121,"is_preprint":false},{"pmid":"22733810","id":"PMC_22733810","title":"MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22733810","citation_count":113,"is_preprint":false},{"pmid":"25500951","id":"PMC_25500951","title":"MafA is critical for maintenance of the mature beta cell phenotype in mice.","date":"2014","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/25500951","citation_count":113,"is_preprint":false},{"pmid":"15664997","id":"PMC_15664997","title":"A crucial role of MafA as a novel therapeutic target for diabetes.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15664997","citation_count":107,"is_preprint":false},{"pmid":"24520122","id":"PMC_24520122","title":"The MafA transcription factor becomes essential to islet β-cells soon after birth.","date":"2014","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/24520122","citation_count":106,"is_preprint":false},{"pmid":"16847327","id":"PMC_16847327","title":"FoxA2, Nkx2.2, and PDX-1 regulate islet beta-cell-specific mafA expression through conserved sequences located between base pairs -8118 and -7750 upstream from the transcription start site.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16847327","citation_count":102,"is_preprint":false},{"pmid":"33067121","id":"PMC_33067121","title":"Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort.","date":"2020","source":"European journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33067121","citation_count":99,"is_preprint":false},{"pmid":"20064392","id":"PMC_20064392","title":"Low-threshold mechanoreceptor subtypes selectively express MafA and are specified by Ret signaling.","date":"2009","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/20064392","citation_count":92,"is_preprint":false},{"pmid":"22150363","id":"PMC_22150363","title":"Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22150363","citation_count":88,"is_preprint":false},{"pmid":"11416124","id":"PMC_11416124","title":"Phosphorylation of MafA is essential for its transcriptional and biological properties.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11416124","citation_count":85,"is_preprint":false},{"pmid":"20424231","id":"PMC_20424231","title":"Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes.","date":"2010","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/20424231","citation_count":85,"is_preprint":false},{"pmid":"37247623","id":"PMC_37247623","title":"Mobile Health-Technology-Integrated Care for Atrial Fibrillation: A Win Ratio Analysis from the mAFA-II Randomized Clinical Trial.","date":"2023","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/37247623","citation_count":85,"is_preprint":false},{"pmid":"17636040","id":"PMC_17636040","title":"MafA regulates expression of genes important to islet beta-cell function.","date":"2007","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/17636040","citation_count":83,"is_preprint":false},{"pmid":"29339498","id":"PMC_29339498","title":"MAFA missense mutation causes familial insulinomatosis and diabetes mellitus.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29339498","citation_count":81,"is_preprint":false},{"pmid":"15862113","id":"PMC_15862113","title":"Relative contribution of PDX-1, MafA and E47/beta2 to the regulation of the human insulin promoter.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15862113","citation_count":81,"is_preprint":false},{"pmid":"15993959","id":"PMC_15993959","title":"Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15993959","citation_count":79,"is_preprint":false},{"pmid":"10741410","id":"PMC_10741410","title":"NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10741410","citation_count":77,"is_preprint":false},{"pmid":"17682063","id":"PMC_17682063","title":"MafA stability in pancreatic beta cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17682063","citation_count":70,"is_preprint":false},{"pmid":"17785922","id":"PMC_17785922","title":"Roles and regulation of transcription factor MafA in islet beta-cells.","date":"2007","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/17785922","citation_count":66,"is_preprint":false},{"pmid":"23801580","id":"PMC_23801580","title":"Ebselen treatment prevents islet apoptosis, maintains intranuclear Pdx-1 and MafA levels, and preserves β-cell mass and function in ZDF rats.","date":"2013","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/23801580","citation_count":63,"is_preprint":false},{"pmid":"8584024","id":"PMC_8584024","title":"The role of the insulin control element and RIPE3b1 activators in glucose-stimulated transcription of the insulin gene.","date":"1995","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8584024","citation_count":62,"is_preprint":false},{"pmid":"25645923","id":"PMC_25645923","title":"Preserving Mafa expression in diabetic islet β-cells improves glycemic control in vivo.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25645923","citation_count":62,"is_preprint":false},{"pmid":"33514698","id":"PMC_33514698","title":"PDX1LOW MAFALOW β-cells contribute to islet function and insulin release.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33514698","citation_count":61,"is_preprint":false},{"pmid":"28223284","id":"PMC_28223284","title":"Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet α-Cells Into β-Cells In Vivo.","date":"2017","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/28223284","citation_count":56,"is_preprint":false},{"pmid":"14680841","id":"PMC_14680841","title":"Mouse MafA, homologue of zebrafish somite Maf 1, contributes to the specific transcriptional activity through the insulin promoter.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14680841","citation_count":56,"is_preprint":false},{"pmid":"34932104","id":"PMC_34932104","title":"The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial.","date":"2021","source":"JAMA network open","url":"https://pubmed.ncbi.nlm.nih.gov/34932104","citation_count":55,"is_preprint":false},{"pmid":"12551916","id":"PMC_12551916","title":"The islet beta cell-enriched RIPE3b1/Maf transcription factor regulates pdx-1 expression.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12551916","citation_count":54,"is_preprint":false},{"pmid":"9674710","id":"PMC_9674710","title":"mafA, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9674710","citation_count":54,"is_preprint":false},{"pmid":"26180087","id":"PMC_26180087","title":"MLL3 and MLL4 Methyltransferases Bind to the MAFA and MAFB Transcription Factors to Regulate Islet β-Cell Function.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26180087","citation_count":53,"is_preprint":false},{"pmid":"29529600","id":"PMC_29529600","title":"Long Noncoding RNA Meg3 Regulates Mafa Expression in Mouse Beta Cells by Inactivating Rad21, Smc3 or Sin3α.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29529600","citation_count":52,"is_preprint":false},{"pmid":"9842918","id":"PMC_9842918","title":"MAFA-L, an ITIM-containing receptor encoded by the human NK cell gene complex and expressed by basophils and NK cells.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9842918","citation_count":51,"is_preprint":false},{"pmid":"17142462","id":"PMC_17142462","title":"Glucose induces MafA expression in pancreatic beta cell lines via the hexosamine biosynthetic pathway.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17142462","citation_count":47,"is_preprint":false},{"pmid":"25628604","id":"PMC_25628604","title":"Cooperation between HMGA1, PDX-1, and MafA is Essential for Glucose-Induced Insulin Transcription in Pancreatic Beta Cells.","date":"2015","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25628604","citation_count":43,"is_preprint":false},{"pmid":"12970735","id":"PMC_12970735","title":"MafA has strong cell transforming ability but is a weak transactivator.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12970735","citation_count":42,"is_preprint":false},{"pmid":"22761608","id":"PMC_22761608","title":"Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells.","date":"2012","source":"Experimental diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/22761608","citation_count":42,"is_preprint":false},{"pmid":"31980627","id":"PMC_31980627","title":"Kindlin-2 modulates MafA and β-catenin expression to regulate β-cell function and mass in mice.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31980627","citation_count":41,"is_preprint":false},{"pmid":"34644565","id":"PMC_34644565","title":"Sex-biased islet β cell dysfunction is caused by the MODY MAFA S64F variant by inducing premature aging and senescence in males.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34644565","citation_count":41,"is_preprint":false},{"pmid":"18515495","id":"PMC_18515495","title":"MafA is a dedicated activator of the insulin gene in vivo.","date":"2008","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18515495","citation_count":40,"is_preprint":false},{"pmid":"20584984","id":"PMC_20584984","title":"Islet beta-cell-specific MafA transcription requires the 5'-flanking conserved region 3 control domain.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20584984","citation_count":40,"is_preprint":false},{"pmid":"19029092","id":"PMC_19029092","title":"Sumoylation regulates the transcriptional activity of MafA in pancreatic beta cells.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19029092","citation_count":40,"is_preprint":false},{"pmid":"22847061","id":"PMC_22847061","title":"Beta cell nuclear musculoaponeurotic fibrosarcoma oncogene family A (MafA) is deficient in type 2 diabetes.","date":"2012","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/22847061","citation_count":40,"is_preprint":false},{"pmid":"15963504","id":"PMC_15963504","title":"MafA transcription factor is phosphorylated by p38 MAP kinase.","date":"2005","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15963504","citation_count":39,"is_preprint":false},{"pmid":"19689288","id":"PMC_19689288","title":"Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells.","date":"2009","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19689288","citation_count":39,"is_preprint":false},{"pmid":"26207953","id":"PMC_26207953","title":"MAFA and T3 Drive Maturation of Both Fetal Human Islets and Insulin-Producing Cells Differentiated From hESC.","date":"2015","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26207953","citation_count":39,"is_preprint":false},{"pmid":"16505238","id":"PMC_16505238","title":"MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic beta-cells.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16505238","citation_count":39,"is_preprint":false},{"pmid":"17449132","id":"PMC_17449132","title":"Role of PDX-1 and MafA as a potential therapeutic target for diabetes.","date":"2007","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/17449132","citation_count":38,"is_preprint":false},{"pmid":"35562869","id":"PMC_35562869","title":"Role of the Transcription Factor MAFA in the Maintenance of Pancreatic β-Cells.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35562869","citation_count":37,"is_preprint":false},{"pmid":"19393272","id":"PMC_19393272","title":"Role of MafA in pancreatic beta-cells.","date":"2009","source":"Advanced drug delivery reviews","url":"https://pubmed.ncbi.nlm.nih.gov/19393272","citation_count":37,"is_preprint":false},{"pmid":"19407223","id":"PMC_19407223","title":"p38 MAPK is a major regulator of MafA protein stability under oxidative stress.","date":"2009","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19407223","citation_count":37,"is_preprint":false},{"pmid":"19004825","id":"PMC_19004825","title":"The stability and transactivation potential of the mammalian MafA transcription factor are regulated by serine 65 phosphorylation.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19004825","citation_count":37,"is_preprint":false},{"pmid":"24312421","id":"PMC_24312421","title":"Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafA.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24312421","citation_count":35,"is_preprint":false},{"pmid":"12217400","id":"PMC_12217400","title":"An unusual inhibitory receptor--the mast cell function-associated antigen (MAFA).","date":"2002","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12217400","citation_count":32,"is_preprint":false},{"pmid":"8566088","id":"PMC_8566088","title":"Proximity relationships between the type I receptor for Fc epsilon (Fc epsilon RI) and the mast cell function-associated antigen (MAFA) studied by donor photobleaching fluorescence resonance energy transfer microscopy.","date":"1996","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8566088","citation_count":32,"is_preprint":false},{"pmid":"18522939","id":"PMC_18522939","title":"MafA and MafB regulate Pdx1 transcription through the Area II control region in pancreatic beta cells.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18522939","citation_count":32,"is_preprint":false},{"pmid":"10744746","id":"PMC_10744746","title":"The RIPE3b1 activator of the insulin gene is composed of a protein(s) of approximately 43 kDa, whose DNA binding activity is inhibited by protein phosphatase treatment.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10744746","citation_count":31,"is_preprint":false},{"pmid":"26904947","id":"PMC_26904947","title":"MafA-Controlled Nicotinic Receptor Expression Is Essential for Insulin Secretion and Is Impaired in Patients with Type 2 Diabetes.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26904947","citation_count":31,"is_preprint":false},{"pmid":"19576197","id":"PMC_19576197","title":"Expression of MafA in pancreatic progenitors is detrimental for pancreatic development.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19576197","citation_count":31,"is_preprint":false},{"pmid":"21278380","id":"PMC_21278380","title":"ATF2 interacts with beta-cell-enriched transcription factors, MafA, Pdx1, and beta2, and activates insulin gene transcription.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21278380","citation_count":30,"is_preprint":false},{"pmid":"33631146","id":"PMC_33631146","title":"The MafA-target gene PPP1R1A regulates GLP1R-mediated amplification of glucose-stimulated insulin secretion in β-cells.","date":"2021","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/33631146","citation_count":30,"is_preprint":false},{"pmid":"35454124","id":"PMC_35454124","title":"MafA Regulation in β-Cells: From Transcriptional to Post-Translational Mechanisms.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/35454124","citation_count":29,"is_preprint":false},{"pmid":"20682694","id":"PMC_20682694","title":"Insulin transactivator MafA regulates intrathymic expression of insulin and affects susceptibility to type 1 diabetes.","date":"2010","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/20682694","citation_count":28,"is_preprint":false},{"pmid":"22776709","id":"PMC_22776709","title":"The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improves the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells.","date":"2012","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/22776709","citation_count":28,"is_preprint":false},{"pmid":"16934222","id":"PMC_16934222","title":"MafA differentiates rat intestinal cells into insulin-producing cells.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16934222","citation_count":28,"is_preprint":false},{"pmid":"17583797","id":"PMC_17583797","title":"Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1beta and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells.","date":"2007","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/17583797","citation_count":26,"is_preprint":false},{"pmid":"20158571","id":"PMC_20158571","title":"MafA promotes the reprogramming of placenta-derived multipotent stem cells into pancreatic islets-like and insulin+ cells.","date":"2011","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20158571","citation_count":26,"is_preprint":false},{"pmid":"21646385","id":"PMC_21646385","title":"Proteasome activator PA28{gamma} stimulates degradation of GSK3-phosphorylated insulin transcription activator MAFA.","date":"2011","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21646385","citation_count":26,"is_preprint":false},{"pmid":"20208071","id":"PMC_20208071","title":"Phosphorylation within the MafA N terminus regulates C-terminal dimerization and DNA binding.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20208071","citation_count":25,"is_preprint":false},{"pmid":"12008030","id":"PMC_12008030","title":"Clustering the mast cell function-associated antigen (MAFA) leads to tyrosine phosphorylation of p62Dok and SHIP and affects RBL-2H3 cell cycle.","date":"2002","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/12008030","citation_count":25,"is_preprint":false},{"pmid":"19624757","id":"PMC_19624757","title":"Neither MafA/L-Maf nor MafB is essential for lens development in mice.","date":"2009","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/19624757","citation_count":25,"is_preprint":false},{"pmid":"17239820","id":"PMC_17239820","title":"Islet cell differentiation in liver by combinatorial expression of transcription factors neurogenin-3, BETA2, and RIPE3b1.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17239820","citation_count":24,"is_preprint":false},{"pmid":"30911681","id":"PMC_30911681","title":"The calcium channel subunit gamma-4 is regulated by MafA and necessary for pancreatic beta-cell specification.","date":"2019","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/30911681","citation_count":24,"is_preprint":false},{"pmid":"23660596","id":"PMC_23660596","title":"Preventing p38 MAPK-mediated MafA degradation ameliorates β-cell dysfunction under oxidative stress.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23660596","citation_count":24,"is_preprint":false},{"pmid":"19937015","id":"PMC_19937015","title":"Definition of Mafa-A and -B haplotypes in pedigreed cynomolgus macaques (Macaca fascicularis).","date":"2009","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19937015","citation_count":23,"is_preprint":false},{"pmid":"25126749","id":"PMC_25126749","title":"MafA is required for postnatal proliferation of pancreatic β-cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25126749","citation_count":22,"is_preprint":false},{"pmid":"31208980","id":"PMC_31208980","title":"MafB Is Important for Pancreatic β-Cell Maintenance under a MafA-Deficient Condition.","date":"2019","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31208980","citation_count":22,"is_preprint":false},{"pmid":"31822804","id":"PMC_31822804","title":"Transcriptome analysis of human brain microvascular endothelial cells response to Neisseria meningitidis and its antigen MafA using RNA-seq.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31822804","citation_count":22,"is_preprint":false},{"pmid":"35872977","id":"PMC_35872977","title":"The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35872977","citation_count":22,"is_preprint":false},{"pmid":"24260156","id":"PMC_24260156","title":"Generation of functional insulin-producing cells from neonatal porcine liver-derived cells by PDX1/VP16, BETA2/NeuroD and MafA.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24260156","citation_count":22,"is_preprint":false},{"pmid":"22623997","id":"PMC_22623997","title":"Memory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22623997","citation_count":22,"is_preprint":false},{"pmid":"24013263","id":"PMC_24013263","title":"Both PAX4 and MAFA are expressed in a substantial proportion of normal human pancreatic alpha cells and deregulated in patients with type 2 diabetes.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24013263","citation_count":21,"is_preprint":false},{"pmid":"26546820","id":"PMC_26546820","title":"Islet-specific monoamine oxidase A and B expression depends on MafA transcriptional activity and is compromised in type 2 diabetes.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26546820","citation_count":21,"is_preprint":false},{"pmid":"24794627","id":"PMC_24794627","title":"Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA.","date":"2014","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/24794627","citation_count":21,"is_preprint":false},{"pmid":"34978761","id":"PMC_34978761","title":"MAFA and MAFB regulate exocytosis-related genes in human β-cells.","date":"2022","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34978761","citation_count":19,"is_preprint":false},{"pmid":"20718938","id":"PMC_20718938","title":"SUMOylation negatively regulates transcriptional and oncogenic activities of MafA.","date":"2010","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/20718938","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47492,"output_tokens":9944,"usd":0.145818,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20367,"output_tokens":5270,"usd":0.116792,"stage2_stop_reason":"end_turn"},"total_usd":0.26261,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"MAFA (RIPE3b1) was identified as the mammalian homologue of avian MafA/L-Maf by biochemical purification and shown to specifically bind the insulin enhancer element RIPE3b and activate insulin gene expression; it is selectively expressed in pancreatic beta cells but not alpha cells.\",\n      \"method\": \"Biochemical purification, DNA binding assay (EMSA), reporter gene assay, RT-PCR\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct biochemical purification plus functional reporter assay, replicated by independent lab same year (PMID:12368292)\",\n      \"pmids\": [\"12011435\", \"12368292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MafA protein and mRNA are up-regulated by glucose in pancreatic beta cells, and MafA binds the RIPE3b element in a glucose-dependent manner; dominant-negative MafA inhibits insulin promoter activity in beta cell lines.\",\n      \"method\": \"RT-PCR, EMSA, transient transfection reporter assay, dominant-negative construct\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (binding assay, reporter assay, dominant-negative), replicated across labs\",\n      \"pmids\": [\"12368292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MafA selectively induces endogenous insulin transcription in non-beta cells, making it the only beta cell-specific activator of the insulin gene; MafA expression is first detected during the second principal phase of beta cell differentiation and is absent in Nkx6.1-null pancreata.\",\n      \"method\": \"Ectopic expression in non-beta cell lines, in vivo mouse genetic model (Nkx6.1-/-), immunostaining\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function genetic model combined with ectopic expression assay, two orthogonal approaches\",\n      \"pmids\": [\"14973194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MafA physically interacts with endogenous PDX-1 and BETA2 (NeuroD) in beta cells, and together these three factors synergistically activate insulin promoter activity; synergy requires MafA transactivation and DNA-binding activity.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, transfection reporter assay, dominant-negative and siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reciprocal Co-IP plus GST pull-down plus functional reporter assays with mutagenesis\",\n      \"pmids\": [\"15665000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MafA-deficient mice display glucose intolerance and develop diabetes mellitus with severely impaired glucose-, arginine-, and KCl-stimulated insulin secretion, reduced Pdx1, Beta2, Glut-2, and insulin transcripts, demonstrating MafA is a key in vivo regulator of glucose-stimulated insulin secretion.\",\n      \"method\": \"Knockout mouse model, glucose tolerance test, insulin secretion assay, RT-PCR\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout mouse with multiple defined phenotypic readouts\",\n      \"pmids\": [\"15923615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"FoxO1 protects beta cells against oxidative stress by forming a complex with PML and SIRT1 to activate MafA (and NeuroD) expression; hyperglycemia suppresses MafA expression in vivo and this can be prevented by constitutively nuclear FoxO1.\",\n      \"method\": \"Coimmunoprecipitation (FoxO1-Pml-Sirt1 complex), acetylation-defective/mimicking mutants, transgenic mouse model, in vivo glucose manipulation\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complex identification by Co-IP plus transgenic mouse rescue experiment\",\n      \"pmids\": [\"16154098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Phosphorylation of MafA at serines 14 and 65 (located in the transcriptional activating domain) is essential for its transcriptional activity and biological functions including induction of differentiation programs; these residues are phosphorylated by ERK2 in vitro.\",\n      \"method\": \"In vitro kinase assay (ERK2), site-directed mutagenesis (S14A, S65A), reporter gene assay, in ovo electroporation differentiation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and functional validation, single lab\",\n      \"pmids\": [\"11416124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FoxA2, Nkx2.2, and PDX-1 bind in vivo to conserved region 3 (bp -8118 to -7750) of the mafA promoter to drive beta cell-specific mafA transcription; Nkx2.2-null animals lack MafA expression in the pancreatic epithelium, and PDX-1 knockdown decreases mafA mRNA.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), EMSA, site-directed mutagenesis, reporter assay, siRNA knockdown, Nkx2.2 knockout mouse\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP plus mutagenesis plus genetic loss-of-function model\",\n      \"pmids\": [\"16847327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MAFA overproduction enhances and dominant-negative MAFA diminishes binding to the insulin promoter, correlating with insulin mRNA and protein levels; MAFA also positively regulates glucokinase, Glut2, PDX1, NKX6-1, GLP1R, PCSK1, and pyruvate carboxylase expression in beta cell lines.\",\n      \"method\": \"Inducible stable cell lines (overexpression and dominant-negative), EMSA, RT-PCR, Western blot, insulin secretion assay\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain- and loss-of-function in isogenic cell lines with multiple target gene readouts\",\n      \"pmids\": [\"17149590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MafA protein stability is regulated by glycogen synthase kinase 3 (GSK3): GSK3 constitutively phosphorylates the MafA N-terminal region at multiple sites, and this phosphorylation is a prerequisite for rapid MafA protein degradation under low-glucose conditions.\",\n      \"method\": \"Mutational analysis of MafA phosphorylation sites, pharmacological GSK3 inhibition in MIN6 beta cells, pulse-chase/degradation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — site-directed mutagenesis combined with pharmacological inhibition and protein stability assay\",\n      \"pmids\": [\"17682063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Phosphorylation at Ser65 of MafA controls both protein stability and transactivation potential; phosphorylation at Ser65 is the initial degradation signal, with ubiquitination occurring in the C-terminus; phosphorylation at Ser65 acts as primer for subsequent GSK3-mediated phosphorylation at neighboring N-terminal residues; Ser65 phosphorylation is required for polyubiquitination.\",\n      \"method\": \"Site-directed mutagenesis (S65E, S65D, S65A), ubiquitination assay, proteasome degradation assay, reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution-level mutagenesis with mechanistic dissection of phosphorylation-ubiquitination cascade\",\n      \"pmids\": [\"19004825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Sumoylation of MafA at Lys32 reduces its transcriptional activity toward the insulin gene promoter and increases repression of the CHOP-10 promoter; low glucose and hydrogen peroxide increase endogenous MafA sumoylation; sumoylation does not affect nuclear localization or ubiquitin-dependent degradation.\",\n      \"method\": \"SUMO modification assay, site-directed mutagenesis (K32R), reporter gene assay, beta cell treatment with glucose/H2O2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct biochemical modification assay with mutagenesis and functional reporter readout\",\n      \"pmids\": [\"19029092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"p38 MAPK directly binds to MafA and regulates MafA protein stability under both basal and oxidative stress conditions; under oxidative stress p38 MAPK-mediated phosphorylation at threonine 57 and threonine 134 drives MafA degradation via the ubiquitin-proteasomal pathway; inhibiting p38 MAPK (but not GSK3) prevents oxidative stress-dependent MafA degradation.\",\n      \"method\": \"p38 MAPK inhibitor treatment, site-directed mutagenesis (T57A, T134A), Co-IP (p38-MafA binding), protein stability assay, isolated mouse islets\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct binding shown by Co-IP, mutagenesis identifies specific phosphorylation sites, functional degradation assay\",\n      \"pmids\": [\"19407223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Phosphorylation within the MafA N-terminal transactivation domain (aa 1-72) is required for C-terminal dimerization and DNA binding; dephosphorylation precludes detection of MafA dimers and dramatically reduces DNA binding; this phosphorylation dependency is unique to MafA and not shared by MafB.\",\n      \"method\": \"Mass spectrometry (phosphorylation site mapping), MafA/MafB chimeric proteins, dephosphorylation assay, EMSA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mass spectrometry plus chimeric protein analysis plus EMSA, identifying a novel structural mechanism\",\n      \"pmids\": [\"20208071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The islet beta cell-enriched RIPE3b1/MafA transcription factor binds to sequence blocks 4 and 5 (B4/5) within the pdx-1 gene Area II control region and activates pdx-1 transcription; ChIP confirmed MafA occupancy at the endogenous pdx-1 Area II region.\",\n      \"method\": \"EMSA, reporter assay with mutagenesis, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct DNA binding (EMSA), promoter mutagenesis, and in vivo ChIP confirming endogenous occupancy\",\n      \"pmids\": [\"12551916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MafA, PDX-1, and BETA2 synergistically activate the insulin promoter; mutagenesis shows at least GG2, C1, and E1 elements (within -150 to -100 bp) are necessary for synergy; neither MafB nor c-Maf shows the same synergistic activation with PDX-1 and BETA2.\",\n      \"method\": \"Transient transfection reporter assay, promoter deletion and mutagenesis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic promoter mutagenesis in beta cell lines, single lab\",\n      \"pmids\": [\"15993959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MafA phosphorylation by p38 MAP kinase occurs at threonine 113, threonine 57, and serine 272; mutation of these residues severely impairs MafA biological activity; p38 also phosphorylates MafB and c-Maf.\",\n      \"method\": \"Western blot, mass spectrometry, in vitro kinase assay, site-directed mutagenesis, reporter/biological activity assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus mass spectrometry identification of sites plus mutagenesis functional validation\",\n      \"pmids\": [\"15963504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Glucose-induced MafA expression in beta cells requires flux through the hexosamine biosynthetic pathway and O-linked glycosylation by UDP-N-acetylglucosaminyl transferase; glucosamine stimulates MafA expression in the absence of high glucose, and inhibition of the hexosamine pathway abolishes glucose-induced MafA induction.\",\n      \"method\": \"Pharmacological inhibition (glucosamine supplementation, hexosamine pathway inhibitors, OGT inhibitor/activator), RT-PCR, Western blot in beta cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection with multiple compounds, single lab, indirect evidence for O-GlcNAc-mediated regulation\",\n      \"pmids\": [\"17142462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"MafA and MafB regulate Pdx1 transcription exclusively through the Area II control region; in adult islets only MafA is bound to Area II by quantitative ChIP; both MafA and MafB are bound to Area II at E18.5 during development; MafB-/- mice show severely compromised Pdx1 Area I/II transgene expression.\",\n      \"method\": \"Transfection reporter assay, quantitative ChIP, MafB knockout mouse model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quantitative ChIP plus loss-of-function mouse model\",\n      \"pmids\": [\"18522939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Region 3 (bp -8118 to -7750) of the mafA promoter is necessary but not sufficient for beta cell-specific in vivo expression; full promoter (R1-6) is required including region 3; Nkx6.1 and Pax6 (but not NeuroD1) bind to and activate MafA through region 3 in ChIP and transfection assays and in vivo knockout models.\",\n      \"method\": \"Transgenic reporter mice (R3, R1-6, R1-6ΔR3), ChIP, EMSA, transfection assay, mouse knockout models\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple transgenic reporter lines, ChIP, and genetic knockout models\",\n      \"pmids\": [\"20584984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ATF2 forms a complex with MafA and acquires the capacity to bind the C1/RIPE3b element; co-expression of ATF2, MafA, PDX-1, and BETA2 produces synergistic activation of the insulin promoter; RNAi knockdown of ATF2 or MafA decreases endogenous insulin mRNA in MIN6 cells.\",\n      \"method\": \"Co-immunoprecipitation, EMSA, reporter assay, RNAi knockdown, immunohistochemistry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus EMSA plus functional knockdown, single lab\",\n      \"pmids\": [\"21278380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Proteasome activator PA28γ binds to GSK3-phosphorylated MAFA, stimulates its proteasomal degradation, and attenuates MAFA-driven insulin promoter activity; MAFA phosphorylation-site mutants (alanine substitutions at Ser49, Thr53, Thr57, Ser61, Ser65) do not bind PA28γ and are resistant to degradation; PA28γ degrades MAFA through a mechanism distinct from p21 degradation.\",\n      \"method\": \"Co-immunoprecipitation (PA28γ-MAFA), proteasome degradation assay, site-directed mutagenesis, reporter assay, PA28γ mutant analysis\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct binding by Co-IP, mutagenesis of phosphorylation sites, functional reporter assay\",\n      \"pmids\": [\"21646385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SUMOylation at a conserved lysine residue in the MafA N-terminal transactivator domain negatively regulates its transcriptional and oncogenic activities; a SUMOylation-deficient mutant (K32R) shows enhanced transactivation of crystallin and insulin promoters and enhanced colony formation.\",\n      \"method\": \"SUMO modification assay, site-directed mutagenesis (K32R), reporter gene assay, in ovo electroporation, colony formation assay\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct SUMO modification assay with mutagenesis and multiple functional readouts\",\n      \"pmids\": [\"20718938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MafA associates with the MLL3 and MLL4 histone H3K4 methyltransferase complexes (~1.5 MDa) in beta cell extracts; all subunits of MLL3/4 complexes were identified by unbiased mass spectrometry; NCOA6 knockdown (a core MLL3/4 subunit) reduces expression of a subset of MafA target genes in mouse and human beta cell lines.\",\n      \"method\": \"In-cell biochemistry/mass spectrometry (unbiased pulldown), size-fractionation Co-IP, siRNA knockdown, islet-specific NCoA6 knockout mouse\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — unbiased mass spectrometry identification plus size-fractionation Co-IP plus genetic knockout validation\",\n      \"pmids\": [\"26180087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Thyroid hormone (T3) has a direct receptor-ligand interaction with the Mafa promoter (shown by ChIP and EMSA) and this interaction is functional in a luciferase reporter assay; dominant-negative Mafa abolishes T3-enhanced glucose-responsive insulin secretion, placing Mafa downstream of thyroid hormone signaling for beta cell functional maturation.\",\n      \"method\": \"Chromatin immunoprecipitation, EMSA, luciferase reporter assay, dominant-negative Mafa, in vivo T3 supplementation/inhibition in neonatal rats\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct promoter binding (ChIP + EMSA), functional reporter, and dominant-negative epistasis in vivo\",\n      \"pmids\": [\"23305647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A missense MAFA mutation (p.Ser64Phe) impairs phosphorylation within the transactivation domain, profoundly increases MAFA protein stability under both high and low glucose, and enhances transactivation potential in beta cell lines, causing familial insulinomatosis or diabetes.\",\n      \"method\": \"Exome sequencing (disease mutation identification), phosphorylation assay, protein stability assay in beta cell lines, reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — biochemical demonstration of impaired phosphorylation and increased stability with multiple assays in two families\",\n      \"pmids\": [\"29339498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The MAFA S64F mutation causes accelerated cellular senescence and increased senescence-associated secretory proteins in male human beta cells; male MafAS64F/+ mice show transiently higher MafA protein levels, sex-dependent changes in Ca2+ signaling, DNA damage, and aging genes preceding glucose intolerance.\",\n      \"method\": \"S64F MafA knock-in mouse model, human beta cell expression system, senescence assays, gene expression profiling\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knock-in mouse model plus human beta cell experiments with functional senescence readouts\",\n      \"pmids\": [\"34644565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"p38 MAPK directly binds to MafA and promotes its degradation through the ubiquitin proteasomal pathway under oxidative stress; degradation under oxidative stress depends specifically on p38 MAPK-mediated phosphorylation at T134 (not T57); expression of T134A-MafA but not T57A-MafA reduces oxidative stress-mediated loss of glucose-stimulated insulin secretion; PA28γ expression is reduced under oxidative stress, explaining the dominance of p38 MAPK over GSK3 in this context.\",\n      \"method\": \"Site-directed mutagenesis (T134A, T57A), Co-IP (p38-MafA), ubiquitin assay, insulin secretion assay, Western blot\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct binding Co-IP plus mutagenesis distinguishing two phosphorylation sites, functional secretion assay\",\n      \"pmids\": [\"23660596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MAFA controls ANS-mediated insulin secretion by activating transcription of nicotinic receptor genes (ChrnB2, ChrnB4) and adrenergic receptor gene (Adra2A) in beta cells; acetylcholine-mediated insulin secretion requires nicotinic signaling; shown in MafA-deficient mouse model and human islet correlation studies.\",\n      \"method\": \"MafA-deficient mouse model, ChIP, reporter assay, insulin secretion assay with nicotinic/adrenergic agonists, human islet gene expression analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function mouse model plus ChIP plus functional insulin secretion assay\",\n      \"pmids\": [\"26904947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MafA directly binds to transcriptional control sequences of MaoA and MaoB genes (monoamine oxidases) in beta cells, activating their expression; MaoB expression is reduced in MafA-deficient mouse islets; inhibition of Mao activity reduces insulin secretion.\",\n      \"method\": \"ChIP (MafA binding to MaoA/MaoB promoters), MafA knockout mouse, pharmacological Mao inhibition, insulin secretion assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP plus loss-of-function mouse model plus functional secretion assay\",\n      \"pmids\": [\"26546820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MafA controls expression of the calcium channel subunit CaVγ4, as verified by ChIP and experiments in beta cell-specific MafA knockout mice; reduced CaVγ4 leads to decreased CaV1.2 and CaV1.3 expression and suppresses voltage-gated Ca2+ entry and glucose-stimulated insulin exocytosis.\",\n      \"method\": \"ChIP (MafA at CaVγ4 locus), beta cell-specific MafA knockout mouse, patch-clamp/Ca2+ imaging, insulin exocytosis assay\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP plus conditional knockout mouse with functional calcium and secretion readouts\",\n      \"pmids\": [\"30911681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MafA regulates expression of the PPP1R1A (protein phosphatase 1 inhibitor protein 1A) gene in beta cells; PPP1R1A silencing impairs GLP1-mediated glucose-stimulated insulin secretion amplification, PKA-target protein phosphorylation, and mitochondrial coupling efficiency, and causes beta cell dedifferentiation.\",\n      \"method\": \"MafA knockout mouse (gene expression profiling), siRNA knockdown of PPP1R1A, insulin secretion assay, PKA phosphorylation assay, mitochondrial coupling assay\",\n      \"journal\": \"Metabolism: clinical and experimental\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in mouse model plus functional beta cell assays, single lab\",\n      \"pmids\": [\"33631146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MAFA and MAFB regulate exocytosis-related genes in human beta cells including STX1A, SYT7, and STXBP1; MAFA/MAFB silencing impairs insulin secretion and reduces STX1A, SYT7, and STXBP1 mRNA; STX1A and STXBP1 protein expression is impaired in islets from T2D donors lacking MAFA.\",\n      \"method\": \"RNAseq (MafA-/- mouse islets), MAFA/MAFB siRNA knockdown in human islets and EndoC-βH1 cells, insulin secretion assay, Western blot\",\n      \"journal\": \"Acta physiologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in mouse and human beta cell models, functional secretion assay, single lab\",\n      \"pmids\": [\"34978761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Kindlin-2 binds to MafA through its C-terminal region, stabilizes MafA protein, and thereby activates insulin expression; Kindlin-2 loss decreases MafA levels and impairs insulin secretion; Kindlin-2 loss also activates GSK-3β and downregulates β-catenin, reducing beta cell proliferation.\",\n      \"method\": \"Conditional beta cell-specific Kindlin-2 knockout mouse, Co-IP (Kindlin-2-MafA), domain mapping, protein stability assay, Ca2+ imaging, insulin secretion assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct Co-IP with domain mapping plus conditional knockout mouse with multiple mechanistic readouts\",\n      \"pmids\": [\"31980627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL3-mediated m6A methylation regulates MafA mRNA stability and expression; METTL3 silencing reduces m6A levels, MafA mRNA stability, and MafA protein; MafA overexpression rescues the impaired glucose-stimulated insulin secretion caused by METTL3 silencing.\",\n      \"method\": \"METTL3 siRNA knockdown, m6A measurement, mRNA stability assay, MafA overexpression rescue, insulin secretion assay in NIT-1 and β-TC-6 cells\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct mRNA stability assay plus epistasis rescue experiment, single lab\",\n      \"pmids\": [\"35872977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss of MafA in knockout mice reduces the beta-to-alpha cell ratio and leads to beta cell dedifferentiation, including reduced/lost insulin expression and conversion of a minority of beta cells to glucagon-expressing cells; re-expression of Mafb (an immature beta cell marker) is observed in dedifferentiated beta cells in MafA KO and diabetic mouse models.\",\n      \"method\": \"MafA knockout mouse, lineage tracing, transcriptome analysis, immunostaining\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — lineage tracing plus transcriptome analysis in knockout model defines cell fate mechanism\",\n      \"pmids\": [\"25500951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MafA regulates postnatal beta cell replication through the prolactin receptor (Prlr) and cyclin D2 (Ccnd2); MafA directly transactivates the Prlr promoter; loss of MafA reduces Prlr and Ccnd2 expression and impairs beta cell proliferation at 4 weeks of age.\",\n      \"method\": \"MafA knockout mouse, transcriptome analysis, reporter assay (Prlr promoter), siRNA knockdown, BrdU proliferation assay, Western blot\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter activation assay plus knockout mouse with proliferation phenotype\",\n      \"pmids\": [\"25126749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Expression of MafA in Pdx1+ pancreatic progenitors reduces pancreatic mass and proliferation of progenitors, at least partially through induction of cyclin kinase inhibitors p27 and p57, and disproportionately inhibits formation of endocrine cells.\",\n      \"method\": \"Conditional MafA transgene expression in Pdx1+ progenitors (in vivo mouse), cell cycle analysis, immunostaining for p27/p57\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional transgenic mouse with mechanistic marker analysis, single lab\",\n      \"pmids\": [\"19576197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MafA is able to bind MARE sequences and heterodimerize with v-Maf, MafB, Jun, and Fos, but not with small Maf proteins (MafF, MafK); increased expression of mafA in neuroretina induces sustained proliferation of postmitotic cells.\",\n      \"method\": \"EMSA, co-immunoprecipitation (heterodimerization), overexpression in QNR cells (proliferation assay)\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — EMSA and Co-IP dimerization assays plus functional proliferation assay, avian ortholog data\",\n      \"pmids\": [\"9674710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MafA cell-transforming ability is correlated with its DNA-binding domain (from chimeric MafA/MafB analysis); transactivation and transformation by MafA are controlled by phosphorylation of two conserved serine residues in the transactivation domain; MafA is a weaker transactivator than MafB or c-Maf but the strongest inducer of cellular transformation.\",\n      \"method\": \"Reporter assay, chicken embryo fibroblast transformation assay, MafA/MafB chimeric proteins, site-directed mutagenesis, MafA-estrogen receptor fusion\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — chimeric protein and mutagenesis analysis with functional transformation assay, single lab\",\n      \"pmids\": [\"12970735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"c-Jun expression is increased in diabetic db/db islets and directly suppresses MafA expression; adenoviral overexpression of c-Jun in MIN6 cells and isolated islets significantly decreases MafA expression and insulin expression; MafA overexpression restores insulin promoter activity suppressed by c-Jun.\",\n      \"method\": \"db/db mouse model (immunohistochemistry, Western blot), adenoviral overexpression of c-Jun, reporter assay, MafA rescue experiment\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function in primary islets plus in vivo pathological correlation and rescue experiment\",\n      \"pmids\": [\"20424231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HMGA1 physically interacts with PDX-1 and MafA both in vitro and in vivo; HMGA1 overexpression enhances the transactivating activity of PDX-1 and MafA on insulin promoters; HMGA1 knockdown decreases this activity; glucose increases HMGA1 binding to the insulin gene promoter.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, reporter assay (overexpression and knockdown), ChIP\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus GST pull-down plus reporter assay, single lab\",\n      \"pmids\": [\"25628604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MafA regulates intrathymic insulin (Ins2) expression; MafA knockout mice show reduced thymic Ins2 expression and develop autoantibodies against pancreatic islets; MafA expression in thymus correlates with Ins2 expression in NOD mice.\",\n      \"method\": \"MafA knockout mouse, RT-PCR (thymic Ins2), autoantibody measurement, reporter assay for MafA polymorphisms\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse with defined thymic gene expression and autoimmunity phenotype, single lab\",\n      \"pmids\": [\"20682694\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAFA is a beta cell-enriched basic leucine zipper transcription factor that binds the RIPE3b/C1 element of the insulin gene promoter and synergistically activates insulin transcription together with PDX-1 and BETA2/NeuroD; its activity and stability are tightly controlled by multi-site phosphorylation (by GSK3, p38 MAPK, and ERK2), SUMOylation at Lys32, and ubiquitin-proteasomal degradation (facilitated by PA28γ), with Ser65 phosphorylation serving as the priming signal for proteolysis; MAFA also directly regulates transcription of Pdx1, genes for glucose sensing, ion channels (CaVγ4), neurotransmitter receptors, and exocytosis machinery, and associates with MLL3/4 histone methyltransferase complexes to broadly activate beta cell gene programs, collectively making MAFA an essential master regulator of adult beta cell identity, glucose-stimulated insulin secretion, and postnatal beta cell proliferation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MAFA is a beta cell-enriched basic leucine zipper transcription factor that serves as a master regulator of adult beta cell identity and glucose-stimulated insulin secretion [#0, #4]. Originally purified as the RIPE3b1 activity that binds the RIPE3b/C1 enhancer element of the insulin gene, it is the only known beta cell-specific factor capable of inducing endogenous insulin transcription in non-beta cells [#0, #2], and it activates insulin transcription synergistically with PDX-1 and BETA2/NeuroD through physical complex formation on the proximal promoter [#3, #15]. MAFA functions at the apex of a beta cell transcriptional network: it directly drives Pdx1 transcription through the Area II control region [#14, #18] while itself being a target of upstream regulators including FoxA2, Nkx2.2, PDX-1, Nkx6.1, and Pax6 that confer beta cell-specific expression [#7, #19]. Beyond insulin, MAFA directly transactivates a broad beta cell functional program — glucose-sensing and metabolic genes [#8], the voltage-gated calcium channel subunit CaVbeta4 governing Ca2+ entry and exocytosis [#30], autonomic neurotransmitter receptors (nicotinic ChrnB2/B4 and adrenergic Adra2A) [#28], monoamine oxidases MaoA/MaoB [#29], and exocytosis machinery [#32], and associates with the ~1.5 MDa MLL3/MLL4 H3K4 methyltransferase complexes to activate these target programs at the chromatin level [#23]. MAFA activity and abundance are governed by an intricate post-translational network: multi-site N-terminal phosphorylation by ERK2, p38 MAPK, and GSK3 is required for dimerization, DNA binding, and transactivation, with Ser65 phosphorylation priming polyubiquitination and proteasomal degradation, the latter facilitated by the proteasome activator PA28gamma [#6, #10, #13, #21]; p38 MAPK-mediated phosphorylation at Thr134 selectively drives MAFA degradation under oxidative stress [#12, #27], while SUMOylation at Lys32 dampens its transactivation [#11, #22]. MAFA is required for postnatal beta cell proliferation through the prolactin receptor and cyclin D2 [#36] and for maintaining differentiated beta cell identity, since its loss causes beta cell dedifferentiation and conversion toward glucagon/MafB-expressing states [#35]. A heterozygous MAFA p.Ser64Phe missense mutation that impairs transactivation-domain phosphorylation and stabilizes the protein causes familial insulinomatosis or diabetes [#25].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Before MAFA's beta cell role was known, its avian ortholog established that transactivation-domain phosphorylation is a prerequisite for Maf transcriptional and differentiation activity, defining the regulatory principle that would later govern MAFA function.\",\n      \"evidence\": \"In vitro ERK2 kinase assay with S14A/S65A mutagenesis and in ovo electroporation differentiation assay\",\n      \"pmids\": [\"11416124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address mammalian beta cell context\", \"Kinases acting in vivo not identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identifying the long-sought RIPE3b1 insulin enhancer activity as the mammalian MAFA established it as a beta cell-selective insulin transcription factor and the molecular basis of glucose-responsive insulin gene control.\",\n      \"evidence\": \"Biochemical purification, EMSA, reporter assay, RT-PCR, plus glucose-dependent binding and dominant-negative inhibition in beta cell lines\",\n      \"pmids\": [\"12011435\", \"12368292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo requirement not yet demonstrated\", \"Mechanism of glucose responsiveness unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that MAFA alone induces endogenous insulin in non-beta cells and is absent in Nkx6.1-null pancreata positioned it as a uniquely sufficient, developmentally regulated beta cell determinant.\",\n      \"evidence\": \"Ectopic expression in non-beta lines and Nkx6.1-/- mouse with immunostaining\",\n      \"pmids\": [\"14973194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect downstream of Nkx6.1 not separated at this stage\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Establishing physical and functional synergy of MAFA with PDX-1 and BETA2, and the in vivo diabetic phenotype of MafA-deficient mice, defined MAFA as a non-redundant node coordinating the insulin transcription complex and glucose-stimulated secretion.\",\n      \"evidence\": \"Co-IP/GST pull-down with reporter mutagenesis, plus knockout mouse with glucose tolerance and insulin secretion assays\",\n      \"pmids\": [\"15665000\", \"15923615\", \"15993959\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and architecture of the trimeric complex unresolved\", \"Distinction between secretory and transcriptional contributions to phenotype incomplete\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mapping the beta cell-specific MafA promoter to a FoxA2/Nkx2.2/PDX-1-bound conserved region placed MAFA within a transcriptional hierarchy and connected its glucose induction to the hexosamine/O-GlcNAc pathway.\",\n      \"evidence\": \"ChIP, EMSA, reporter mutagenesis, Nkx2.2 knockout, and pharmacological hexosamine pathway dissection\",\n      \"pmids\": [\"16847327\", \"17142462\", \"17149590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct O-GlcNAc modification of MAFA itself not established\", \"Promoter-level regulators incompletely enumerated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolving the Ser65-primed phosphorylation/ubiquitination cascade and Lys32 SUMOylation revealed how kinase signaling and SUMO converge to tune MAFA stability and transcriptional output as a glucose- and stress-responsive rheostat.\",\n      \"evidence\": \"Site-directed mutagenesis (S65 variants, K32R), ubiquitination/degradation assays, reporter assays, and GSK3 pharmacology\",\n      \"pmids\": [\"19004825\", \"19029092\", \"17682063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating C-terminal ubiquitination not identified\", \"SUMO ligase/protease not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that N-terminal phosphorylation is required for C-terminal dimerization and DNA binding uncovered a MAFA-unique structural mechanism coupling signaling to DNA occupancy.\",\n      \"evidence\": \"Mass spectrometry site mapping, MafA/MafB chimeras, dephosphorylation assay, EMSA\",\n      \"pmids\": [\"20208071\", \"20718938\", \"20584984\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of phosphorylation-dependent dimerization not solved\", \"Which physiological kinase sets the DNA-binding-competent state in beta cells unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying PA28gamma as the activator coupling GSK3-phosphorylated MAFA to proteasomal degradation, and ATF2 as a partner enhancing insulin promoter synergy, expanded both the destruction and the assembly arms of MAFA regulation.\",\n      \"evidence\": \"Co-IP, proteasome degradation assays, phosphosite mutagenesis (PA28gamma); Co-IP, EMSA, RNAi (ATF2)\",\n      \"pmids\": [\"21646385\", \"21278380\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PA28gamma acts ubiquitin-dependently or independently not fully resolved\", \"ATF2 contribution in vivo untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defining thyroid hormone as a direct upstream input to the Mafa promoter and Thr134-specific p38 phosphorylation as the oxidative-stress degradation trigger linked MAFA to functional maturation signals and stress vulnerability.\",\n      \"evidence\": \"ChIP/EMSA/reporter with dominant-negative epistasis in neonatal rats; T134A/T57A mutagenesis with Co-IP and insulin secretion assays\",\n      \"pmids\": [\"23305647\", \"23660596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crosstalk between maturation signals and stress-driven degradation not integrated\", \"p38 upstream activators in beta cells not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Knockout studies established that MAFA is required to maintain differentiated beta cell identity and to drive postnatal beta cell replication, extending its role from gene activation to cell-fate stability and proliferation.\",\n      \"evidence\": \"MafA knockout mice with lineage tracing, transcriptome analysis; Prlr promoter reporter and BrdU proliferation assays\",\n      \"pmids\": [\"25500951\", \"25126749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism converting beta cells toward glucagon/MafB states incompletely defined\", \"Direct vs indirect control of proliferation machinery partially resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovering MAFA association with MLL3/MLL4 H3K4 methyltransferase complexes and the HMGA1 coactivator provided the chromatin-level mechanism by which MAFA broadly activates beta cell gene programs.\",\n      \"evidence\": \"Unbiased mass spectrometry, size-fractionation Co-IP, NCOA6 knockdown/knockout; Co-IP, GST pull-down, ChIP for HMGA1\",\n      \"pmids\": [\"26180087\", \"25628604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide MAFA-dependent H3K4 methylation landscape not mapped\", \"Recruitment determinants of MLL3/4 by MAFA unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying the MAFA p.Ser64Phe mutation that impairs phosphorylation and stabilizes the protein causally linked MAFA dysregulation to a human Mendelian disease spectrum of insulinomatosis and diabetes.\",\n      \"evidence\": \"Exome sequencing in two families, phosphorylation and protein stability assays, reporter assays in beta cell lines\",\n      \"pmids\": [\"29339498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why the same mutation causes opposite phenotypes (insulinomatosis vs diabetes) unresolved at this stage\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mapping direct MAFA targets to calcium-channel, monoamine oxidase, and autonomic neurotransmitter receptor genes mechanistically connected MAFA to the secretory coupling machinery beyond insulin gene transcription.\",\n      \"evidence\": \"ChIP and beta cell-specific MafA knockout mice with patch-clamp/Ca2+ imaging, Mao inhibition, and insulin secretion assays\",\n      \"pmids\": [\"30911681\", \"26546820\", \"26904947\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of each target to overall secretory defect not quantified\", \"Direct ChIP for all targets not uniformly established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating MAFA control of exocytosis genes and PPP1R1A, its stabilization by Kindlin-2, m6A-dependent MafA mRNA control by METTL3, and S64F-driven senescence built a layered picture of MAFA regulation spanning mRNA stability, protein stability, secretory effectors, and beta cell aging.\",\n      \"evidence\": \"siRNA in human/mouse islets and cell lines, RNAseq, Co-IP/domain mapping, m6A and mRNA stability assays, S64F knock-in mouse with senescence assays\",\n      \"pmids\": [\"34978761\", \"33631146\", \"31980627\", \"35872977\", \"34644565\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Several effector links rest on single-lab loss-of-function without orthogonal in vivo confirmation\", \"Sex-dependence of S64F senescence mechanism not fully explained\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple converging post-translational inputs (ERK2, p38, GSK3, PA28gamma, SUMO, Kindlin-2) and upstream signals are integrated in vivo to set MAFA dosage during health, stress, and the divergent S64F disease outcomes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated quantitative model of MAFA stability control\", \"E3 ligase and SUMO enzymes for MAFA unidentified\", \"Genome-wide direct target/chromatin map in primary human beta cells incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 3, 8, 14, 28, 30]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 13, 14, 38]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11, 0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 3, 8, 14]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 35, 36]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [25, 26]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [23]}\n    ],\n    \"complexes\": [\n      \"MLL3/MLL4 H3K4 methyltransferase complex\",\n      \"MAFA-PDX-1-BETA2/NeuroD insulin promoter complex\"\n    ],\n    \"partners\": [\n      \"PDX1\",\n      \"NEUROD1\",\n      \"ATF2\",\n      \"PA28gamma\",\n      \"HMGA1\",\n      \"FERMT2\",\n      \"MAPK14\",\n      \"NCOA6\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}